Supreme Court on Patent Law for October 2022
Patently-O
SEPTEMBER 26, 2022
Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) The need for terminal disclaimers was greatly reduced following the 1995-GATT patent term transformation.
125 
Let's personalize your content